2,000 Patients Treated with Kuros’ MagnetOs Bone Graft

Kuros Biosciences MagnetOs

Over 2,000 patients have been treated worldwide with Kuros Biosciences' MagnetOs bone graft, an alternative to the gold standard treatment of autograft. The product launched in the U.K. in 2017.

MagnetOs' submicron surface structure, applied during manufacturing, is designed to direct early wound healing toward a bone-forming pathway to...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us